Feel Therapeutics Selected to Join Johnson & Johnson Innovation–JLABS to Catalyze their Vision of Digital Precision Medicine in Mental Health
09 mai 2023 08h30 HE
|
Feel Therapeutics
SAN FRANCISCO, May 09, 2023 (GLOBE NEWSWIRE) -- Feel Therapeutics, a leading digital precision medicine company, is proud to announce that it has been accepted into Johnson & Johnson...
BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue
25 juin 2018 08h00 HE
|
BIOLIFE4D Corporation
CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully...
BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology
29 mai 2018 08h02 HE
|
BIOLIFE4D Corporation
CHICAGO, May 29, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is now a resident...
Amarantus to Present at LD Micro and The Reg A Conference
24 mai 2018 11h00 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, May 24, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTCPink:AMBS) (the "Company," or AMBS), a US-based JLABS-alumnus biotechnology holding company,...
Amarantus Provides Business Overview
11 mai 2018 10h25 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, May 11, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company," or AMBS), a US-based JLABS-alumnus biotechnology holding company,...
Amarantus Appoints Barney Monte as Interim COO/CFO and Promotes Brian Harvey to Chief Regulatory Advisor
05 avr. 2018 08h00 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, April 05, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company,...